Logo

Polski Bank Komórek Macierzystych

Corporate International
  • Stem cells
    • Therapeutic Product of Advanced Therapy
    • Mesenchymal stem cells
  • About Institute
    • What are we?
    • Our team
    • Walk on Institute
    • Institute at conferences
    • Diseases treated
  • For Patient
    • Amytotrophic lateral sclerosis (ALS)
    • Rare neurogenerative diseases
    • Self-help book for patients
    • Secondary-progressive multiple sclerosis SPMS
    • FAQ
  • For Doctors
  • News
    • Webinar: Mesenchymal stem cells - current therapeutic trend
    • We confirm efficacy of intrathecal injection of Wharton’s jelly-derived mesenchymal stem cells!
    • ITK researchers validated the international Amyotrophic Lateral Sclerosis Functional Rating Scale
    • Unproven cell-based therapies – what are they? ITK’s position statement
    • We confirm safety of intrathecal injection of Wharton’s jelly-derived mesenchymal stem cells!
  • Contact
    • Write Us
    • Contact details
Corporate International
  • Stem cells
    • Therapeutic Product of Advanced Therapy
    • Mesenchymal stem cells
  • About Institute
    • What are we?
    • Our team
    • Walk on Institute
    • Institute at conferences
    • Diseases treated
  • For Patient
    • Amytotrophic lateral sclerosis (ALS)
    • Rare neurogenerative diseases
    • Self-help book for patients
    • Secondary-progressive multiple sclerosis SPMS
    • FAQ
  • For Doctors
  • News
    • Webinar: Mesenchymal stem cells - current therapeutic trend
    • We confirm efficacy of intrathecal injection of Wharton’s jelly-derived mesenchymal stem cells!
    • ITK researchers validated the international Amyotrophic Lateral Sclerosis Functional Rating Scale
    • Unproven cell-based therapies – what are they? ITK’s position statement
    • We confirm safety of intrathecal injection of Wharton’s jelly-derived mesenchymal stem cells!
  • Contact
    • Write Us
    • Contact details
 
x

Estonia

Hiszpania (Lab)

Litwa

Luksemburg

Łotwa

Polska (Lab)

Portugalia (Lab)

Rumunia (Lab)

Szwajcaria (Lab)

Turcja (Lab)

Węgry (Lab)

Włochy

Albania

Bośnia i Hercegowina

Chorwacja

Czarnogóra

Dania

Egipt

Kosowo

Macedonia

Niemcy

Serbia

Słowenia

Szwecja

Ukraina

Wielka Brytania

ITK

Who we are?

More Who we are? Instytut Terapii Komórkowych (the Cell Therapies Institute) is a medical entity specialised in an innovative therapy in which use is made ofmesenchymal stem cells.

More about therapy

More
More about therapy The Therapy has the nature of a medical treatment experiment. It is dedicated to adult patients with Amyothropic Lateral Sclerosis, Secondary Progressive Multiple Sclerosis and rare neurodegenerative...

Walk on Institute

More
Walk on Institute

Diseases treated

More
Diseases treated

Our Team

More
Our Team The Medical Team of the Cell Therapy Institute comprises specialists with clinical experience gained among others in theChair of Neurology and Neurosurgery of the Faculty of Medical Sciences in the Un...

Our partners

Important information

  • Privacy policy
  • Policy for processing personal data
  • Site map

Your data

  • News
  • Write Us
  • Contact details

Contact

Instytut Terapii Komórkowych S.A.
ulica Warszawska 30,
Building No 7
10-082 Olsztyn
NIP: 7393869683
Tel: +48 895 245 656
Hotline: +48 517 868 949

Copyright © 2020 Polski Bank Komórek Macierzystych. All rights reserved.

remove-2 plus file mail linkedin facebook instagram twitter youtube upload-button

Information about the use of cookies

This website uses cookies. For more information and how to delete cookies, please read our cookie policy See more...